Join us for a one hour launch briefing for the third iteration of the sexual and reproductive health G-FINDER report.   

Since 2018, the G-FINDER project has tracked global R&D funding for sexual and reproductive health (SRH) products or technologies that are relevant to, fill gaps, and are appropriate for people in low- and middle-income country contexts – particularly women and girls – where the need is greatest.

This report revisits findings from our previous SRH G-FINDER report with FY2018 data and adds three further years of data from FY2019 to FY2021.

The SRH G-FINDER report covers the following issues: sexually transmitted infections, HPV and related cervical cancer,  contraception, multipurpose prevention technologies, preeclampsia & eclampsia, postpartum haemorrhage and R&D for more than one issue. G-FINDER data on HIV/AIDS, hepatitis B, and hepatitis C can be found in the G-FINDER neglected disease report.